progen pharmaceuticals ltd
(PGL:Australian Stock Exchange Ltd)
Philip Johnson M.D., F.R.C.P
Former Member of Clinical Advisory Board, Progen Pharmaceuticals Limited
|Age||Total Calculated Compensation||This person is connected to 26 board members in 2 different organizations across 3 different industries.|
See Board Relationships
Prof. Philip J. Johnson MD, FRCP serves as Principal Advisor of Biocompatibles International Plc. Prof. Johnson serves as Clinical Head of Cancer Research UK Institute for Cancer Studies, University of Birmingham. He serves as Professor of Oncology and Translational Research at the Cancer Research UK Institute for Cancer Studies, University of Birmingham. In 1992, he was appointed to the Chair of Clinical Oncology at the Chinese University of Hong Kong where he also ...
2806 Ipswich RoadPhone: 61 7 3273 9133
Darra, Queensland 4076
Fax: 61 7 3375 1168
Board Members Memberships*There is no Board Members Memberships data available.
University of Manchester
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|
Post a JobJobs
- New York, NY | JPMorgan ChasePosted: Dec 06
- Alexandria, VA |Posted: Dec 06
- Detroit, MI | Wayne State UniversityPosted: Nov 26
- New York, NY | AGORAPosted: Nov 25